{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:25:42Z","timestamp":1787981142889,"version":"build-2784847793"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Probiotics & Antimicro. Prot."],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12602-024-10296-2","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T04:01:59Z","timestamp":1716868919000},"page":"3319-3337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Antimicrobial Peptide\u00a0Tilapia Piscidin 4 Induced the Apoptosis of Bladder Cancer Through ERK\/SIRT1\/PGC-1\u03b1 Signaling Pathway"],"prefix":"10.1007","volume":"17","author":[{"given":"Chun-Feng","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Chih","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Chen","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieh-Yu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Min","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan-Ju","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Ying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Yi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Hong","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hsing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,28]]},"reference":[{"issue":"3","key":"10296_CR1","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.urolonc.2017.12.018","volume":"36","author":"JL Godwin","year":"2018","unstructured":"Godwin JL, Hoffman-Censits J, Plimack E (2018) Recent developments in the treatment of advanced bladder cancer. Urol Oncol 36(3):109\u2013114. https:\/\/doi.org\/10.1016\/j.urolonc.2017.12.018","journal-title":"Urol Oncol"},{"issue":"6","key":"10296_CR2","doi-asserted-by":"publisher","first-page":"e1108","DOI":"10.1016\/j.clgc.2019.07.019","volume":"17","author":"AM Harraz","year":"2019","unstructured":"Harraz AM, El-Shabrawy M, El-Nahas AR, El-Kappany H, Osman Y (2019) Single Versus Maintenance Intravesical Chemotherapy for the Prevention of Bladder Recurrence after Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma: A Randomized Clinical Trial. Clin Genitourin Cancer 17(6):e1108\u2013e1115. https:\/\/doi.org\/10.1016\/j.clgc.2019.07.019","journal-title":"Clin Genitourin Cancer"},{"issue":"9","key":"10296_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2023.103692","volume":"28","author":"S Patra","year":"2023","unstructured":"Patra S, Praharaj PP, Singh A, Bhutia SK (2023) Targeting SIRT1-regulated autophagic cell death as a novel therapeutic avenue for cancer prevention. Drug Discov Today 28(9):103692. https:\/\/doi.org\/10.1016\/j.drudis.2023.103692","journal-title":"Drug Discov Today"},{"issue":"1","key":"10296_CR4","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/s41392-022-01257-8","volume":"7","author":"QJ Wu","year":"2022","unstructured":"Wu QJ, Zhang TN, Chen HH, Yu XF, Lv JL, Liu YY et al (2022) The sirtuin family in health and disease. Signal Transduct Target Ther 7(1):402. https:\/\/doi.org\/10.1038\/s41392-022-01257-8","journal-title":"Signal Transduct Target Ther"},{"issue":"5","key":"10296_CR5","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/procel\/pwac039","volume":"14","author":"F Liu","year":"2023","unstructured":"Liu F, Pang N, Xu RM, Yang N (2023) Mechanism and design of allosteric activators of SIRT1. Protein Cell 14(5):387\u2013392. https:\/\/doi.org\/10.1093\/procel\/pwac039","journal-title":"Protein Cell"},{"issue":"6","key":"10296_CR6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.40463","volume":"15","author":"DI Razick","year":"2023","unstructured":"Razick DI, Akhtar M, Wen J, Alam M, Dean N, Karabala M et al (2023) The Role of Sirtuin 1 (SIRT1) in Neurodegeneration. Cureus 15(6):e40463. https:\/\/doi.org\/10.7759\/cureus.40463","journal-title":"Cureus"},{"key":"10296_CR7","doi-asserted-by":"publisher","unstructured":"Cheng Y, Chen J, Shi Y, Fang X, Tang Z (2022) MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy. Cancers (Basel) 14(19). https:\/\/doi.org\/10.3390\/cancers14194625","DOI":"10.3390\/cancers14194625"},{"key":"10296_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106398","volume":"184","author":"J Anjum","year":"2022","unstructured":"Anjum J, Mitra S, Das R, Alam R, Mojumder A, Emran TB et al (2022) A renewed concept on the MAPK signaling pathway in cancers: Polyphenols as a choice of therapeutics. Pharmacol Res 184:106398. https:\/\/doi.org\/10.1016\/j.phrs.2022.106398","journal-title":"Pharmacol Res"},{"key":"10296_CR9","doi-asserted-by":"publisher","unstructured":"Sugiura R, Satoh R, Takasaki T (2021) ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer. Cells 10(10). https:\/\/doi.org\/10.3390\/cells10102509","DOI":"10.3390\/cells10102509"},{"issue":"1","key":"10296_CR10","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1186\/s12935-022-02666-z","volume":"22","author":"ES Ali","year":"2022","unstructured":"Ali ES, Akter S, Ramproshad S, Mondal B, Riaz TA, Islam MT et al (2022) Targeting Ras-ERK cascade by bioactive natural products for potential treatment of cancer: an updated overview. Cancer Cell Int 22(1):246. https:\/\/doi.org\/10.1186\/s12935-022-02666-z","journal-title":"Cancer Cell Int"},{"key":"10296_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2021.114808","volume":"193","author":"M Xia","year":"2021","unstructured":"Xia M, Cao H, Zheng J, Yao Y, Xu F, Lu G et al (2021) A novel stilbene derivative (GMQ3) suppressed proliferation and induced apoptosis in lung cancer via the p38-MAPK\/SIRT1 pathway. Biochem Pharmacol 193:114808. https:\/\/doi.org\/10.1016\/j.bcp.2021.114808","journal-title":"Biochem Pharmacol"},{"key":"10296_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2020.118787","volume":"265","author":"K Khongsti","year":"2021","unstructured":"Khongsti K, Das KB, Das B (2021) MAPK pathway and SIRT1 are involved in the down-regulation of secreted osteopontin expression by genistein in metastatic cancer cells. Life Sci 265:118787. https:\/\/doi.org\/10.1016\/j.lfs.2020.118787","journal-title":"Life Sci"},{"key":"10296_CR13","doi-asserted-by":"publisher","first-page":"7777","DOI":"10.2147\/OTT.S159095","volume":"11","author":"J Wang","year":"2018","unstructured":"Wang J, Li J, Cao N, Li Z, Han J, Li L (2018) Resveratrol, an activator of SIRT1, induces protective autophagy in non-small-cell lung cancer via inhibiting Akt\/mTOR and activating p38-MAPK. Onco Targets Ther 11:7777\u20137786. https:\/\/doi.org\/10.2147\/OTT.S159095","journal-title":"Onco Targets Ther"},{"issue":"14","key":"10296_CR14","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1055\/s-0033-1350619","volume":"79","author":"HJ Lee","year":"2013","unstructured":"Lee HJ, Auh QS, Lee YM, Kang SK, Chang SW, Lee DS et al (2013) Growth inhibition and apoptosis-inducing effects of cudraflavone B in human oral cancer cells via MAPK, NF-kappaB, and SIRT1 signaling pathway. Planta Med 79(14):1298\u20131306. https:\/\/doi.org\/10.1055\/s-0033-1350619","journal-title":"Planta Med"},{"issue":"3","key":"10296_CR15","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1111\/jam.15314","volume":"132","author":"M Erdem Buyukkiraz","year":"2022","unstructured":"Erdem Buyukkiraz M, Kesmen Z (2022) Antimicrobial peptides (AMPs): A promising class of antimicrobial compounds. J Appl Microbiol 132(3):1573\u20131596. https:\/\/doi.org\/10.1111\/jam.15314","journal-title":"J Appl Microbiol"},{"key":"10296_CR16","doi-asserted-by":"publisher","unstructured":"Tang Z, Ma Q, Chen X, Chen T, Ying Y, Xi X et al (2021) Recent Advances and Challenges in Nanodelivery Systems for Antimicrobial Peptides (AMPs). Antibiotics (Basel) 10(8). https:\/\/doi.org\/10.3390\/antibiotics10080990","DOI":"10.3390\/antibiotics10080990"},{"key":"10296_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.616979","volume":"12","author":"GS Dijksteel","year":"2021","unstructured":"Dijksteel GS, Ulrich MMW, Middelkoop E, Boekema B (2021) Review: Lessons Learned From Clinical Trials Using Antimicrobial Peptides (AMPs). Front Microbiol 12:616979. https:\/\/doi.org\/10.3389\/fmicb.2021.616979","journal-title":"Front Microbiol"},{"key":"10296_CR18","doi-asserted-by":"publisher","unstructured":"Raileanu M, Bacalum M (2023) Cancer Wars: Revenge of the AMPs (Antimicrobial Peptides), a New Strategy against Colorectal Cancer. Toxins (Basel) 15(7).\u00a0https:\/\/doi.org\/10.3390\/toxins15070459","DOI":"10.3390\/toxins15070459"},{"key":"10296_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105777","volume":"171","author":"S Aghamiri","year":"2021","unstructured":"Aghamiri S, Zandsalimi F, Raee P, Abdollahifar MA, Tan SC, Low TY et al (2021) Antimicrobial peptides as potential therapeutics for breast cancer. Pharmacol Res 171:105777. https:\/\/doi.org\/10.1016\/j.phrs.2021.105777","journal-title":"Pharmacol Res"},{"key":"10296_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.105529","volume":"167","author":"S Chauhan","year":"2021","unstructured":"Chauhan S, Dhawan DK, Saini A, Preet S (2021) Antimicrobial peptides against colorectal cancer-a focused review. Pharmacol Res 167:105529. https:\/\/doi.org\/10.1016\/j.phrs.2021.105529","journal-title":"Pharmacol Res"},{"key":"10296_CR21","doi-asserted-by":"publisher","unstructured":"Ting CH, Chen JY (2018) Nile Tilapia Derived TP4 Shows Broad Cytotoxicity Toward to Non-Small-Cell Lung Cancer Cells. Mar Drugs 16(12).\u00a0https:\/\/doi.org\/10.3390\/md16120506","DOI":"10.3390\/md16120506"},{"issue":"26","key":"10296_CR22","doi-asserted-by":"publisher","first-page":"40329","DOI":"10.18632\/oncotarget.9612","volume":"7","author":"CH Ting","year":"2016","unstructured":"Ting CH, Chen YC, Wu CJ, Chen JY (2016) Targeting FOSB with a cationic antimicrobial peptide, TP4, for treatment of triple-negative breast cancer. Oncotarget 7(26):40329\u201340347. https:\/\/doi.org\/10.18632\/oncotarget.9612","journal-title":"Oncotarget"},{"key":"10296_CR23","doi-asserted-by":"publisher","unstructured":"Ting CH, Liu YC, Lyu PC, Chen JY (2018) Nile Tilapia Derived Antimicrobial Peptide TP4 Exerts Antineoplastic Activity Through Microtubule Disruption. Mar Drugs 16(12).\u00a0https:\/\/doi.org\/10.3390\/md16120462","DOI":"10.3390\/md16120462"},{"key":"10296_CR24","doi-asserted-by":"publisher","unstructured":"Su BC, Hung GY, Tu YC, Yeh WC, Lin MC, Chen JY (2021) Marine Antimicrobial Peptide TP4 Exerts Anticancer Effects on Human Synovial Sarcoma Cells via Calcium Overload, Reactive Oxygen Species Production and Mitochondrial Hyperpolarization. Mar Drugs 19(2). https:\/\/doi.org\/10.3390\/md19020093","DOI":"10.3390\/md19020093"},{"issue":"1\u20132","key":"10296_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11010-019-03643-3","volume":"464","author":"BC Su","year":"2020","unstructured":"Su BC, Chen JY (2020) Pharmacological inhibition of p38 potentiates antimicrobial peptide TP4-induced cell death in glioblastoma cells. Mol Cell Biochem 464(1\u20132):1\u20139. https:\/\/doi.org\/10.1007\/s11010-019-03643-3","journal-title":"Mol Cell Biochem"},{"key":"10296_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.114403","volume":"184","author":"AJ Jhou","year":"2021","unstructured":"Jhou AJ, Chang HC, Hung CC, Lin HC, Lee YC, Liu WT et al (2021) Chlorpromazine, an antipsychotic agent, induces G2\/M phase arrest and apoptosis via regulation of the PI3K\/AKT\/mTOR-mediated autophagy pathways in human oral cancer. Biochem Pharmacol 184:114403. https:\/\/doi.org\/10.1016\/j.bcp.2020.114403","journal-title":"Biochem Pharmacol"},{"issue":"7","key":"10296_CR27","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1038\/s41571-020-0341-y","volume":"17","author":"BA Carneiro","year":"2020","unstructured":"Carneiro BA, El-Deiry WS (2020) Targeting apoptosis in cancer therapy. Nat Rev Clin Oncol 17(7):395\u2013417. https:\/\/doi.org\/10.1038\/s41571-020-0341-y","journal-title":"Nat Rev Clin Oncol"},{"key":"10296_CR28","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-023-00629-4","author":"PE Czabotar","year":"2023","unstructured":"Czabotar PE, Garcia-Saez AJ (2023) Mechanisms of BCL-2 family proteins in mitochondrial apoptosis. Nat Rev Mol Cell Biol. https:\/\/doi.org\/10.1038\/s41580-023-00629-4","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"10296_CR29","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12929-022-00859-2","volume":"29","author":"CL Kuo","year":"2022","unstructured":"Kuo CL, Ponneri Babuharisankar A, Lin YC, Lien HW, Lo YK, Chou HY et al (2022) Mitochondrial oxidative stress in the tumor microenvironment and cancer immunoescape: foe or friend? J Biomed Sci 29(1):74. https:\/\/doi.org\/10.1186\/s12929-022-00859-2","journal-title":"J Biomed Sci"},{"issue":"28","key":"10296_CR30","doi-asserted-by":"publisher","first-page":"21590","DOI":"10.1074\/jbc.M109.070169","volume":"285","author":"K Aquilano","year":"2010","unstructured":"Aquilano K, Vigilanza P, Baldelli S, Pagliei B, Rotilio G, Ciriolo MR (2010) Peroxisome proliferator-activated receptor gamma co-activator 1alpha (PGC-1alpha) and sirtuin 1 (SIRT1) reside in mitochondria: possible direct function in mitochondrial biogenesis. J Biol Chem 285(28):21590\u201321599. https:\/\/doi.org\/10.1074\/jbc.M109.070169","journal-title":"J Biol Chem"},{"issue":"12","key":"10296_CR31","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1158\/1078-0432.CCR-14-2290","volume":"21","author":"TT Vellinga","year":"2015","unstructured":"Vellinga TT, Borovski T, de Boer VC, Fatrai S, van Schelven S, Trumpi K et al (2015) SIRT1\/PGC1alpha-Dependent Increase in Oxidative Phosphorylation Supports Chemotherapy Resistance of Colon Cancer. Clin Cancer Res 21(12):2870\u20132879. https:\/\/doi.org\/10.1158\/1078-0432.CCR-14-2290","journal-title":"Clin Cancer Res"},{"issue":"2","key":"10296_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.14348\/molcells.2016.2318","volume":"39","author":"BL Tang","year":"2016","unstructured":"Tang BL (2016) Sirt1 and the Mitochondria. Mol Cells 39(2):87\u201395. https:\/\/doi.org\/10.14348\/molcells.2016.2318","journal-title":"Mol Cells"},{"key":"10296_CR33","doi-asserted-by":"publisher","first-page":"12205","DOI":"10.2147\/CMAR.S273442","volume":"12","author":"D Qiu","year":"2020","unstructured":"Qiu D, Zhu Y, Cong Z (2020) YAP Triggers Bladder Cancer Proliferation by Affecting the MAPK Pathway. Cancer Manag Res 12:12205\u201312214. https:\/\/doi.org\/10.2147\/CMAR.S273442","journal-title":"Cancer Manag Res"},{"key":"10296_CR34","doi-asserted-by":"publisher","unstructured":"Asma ST, Acaroz U, Imre K, Morar A, Shah SRA, Hussain SZ et al (2022) Natural Products\/Bioactive Compounds as a Source of Anticancer Drugs. Cancers (Basel) 14(24). https:\/\/doi.org\/10.3390\/cancers14246203","DOI":"10.3390\/cancers14246203"},{"issue":"1","key":"10296_CR35","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1007\/s40199-019-00273-4","volume":"27","author":"M Nigam","year":"2019","unstructured":"Nigam M, Suleria HAR, Farzaei MH, Mishra AP (2019) Marine anticancer drugs and their relevant targets: a treasure from the ocean. Daru 27(1):491\u2013515. https:\/\/doi.org\/10.1007\/s40199-019-00273-4","journal-title":"Daru"},{"key":"10296_CR36","doi-asserted-by":"publisher","unstructured":"Onyiba CI, Scarlett CJ, Weidenhofer J (2022) The Mechanistic Roles of Sirtuins in Breast and Prostate Cancer. Cancers (Basel) 14(20).\u00a0https:\/\/doi.org\/10.3390\/cancers14205118","DOI":"10.3390\/cancers14205118"},{"issue":"24","key":"10296_CR37","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000020685","volume":"99","author":"Z Zeng","year":"2020","unstructured":"Zeng Z, Huang Y, Li Y, Huang S, Wang J, Tang Y et al (2020) Gene expression and prognosis of sirtuin family members in ovarian cancer. Medicine (Baltimore) 99(24):e20685. https:\/\/doi.org\/10.1097\/MD.0000000000020685","journal-title":"Medicine (Baltimore)"},{"issue":"26","key":"10296_CR38","doi-asserted-by":"publisher","first-page":"6772","DOI":"10.1021\/acs.jafc.8b01831","volume":"66","author":"Y Zang","year":"2018","unstructured":"Zang Y, Fan L, Chen J, Huang R, Qin H (2018) Improvement of Lipid and Glucose Metabolism by Capsiate in Palmitic Acid-Treated HepG2 Cells via Activation of the AMPK\/SIRT1 Signaling Pathway. J Agric Food Chem 66(26):6772\u20136781. https:\/\/doi.org\/10.1021\/acs.jafc.8b01831","journal-title":"J Agric Food Chem"},{"key":"10296_CR39","doi-asserted-by":"publisher","first-page":"1516","DOI":"10.3389\/fonc.2019.01516","volume":"9","author":"L Edatt","year":"2019","unstructured":"Edatt L, Poyyakkara A, Raji GR, Ramachandran V, Shankar SS, Kumar VBS (2019) Role of Sirtuins in Tumor Angiogenesis. Front Oncol 9:1516. https:\/\/doi.org\/10.3389\/fonc.2019.01516","journal-title":"Front Oncol"},{"key":"10296_CR40","doi-asserted-by":"publisher","unstructured":"Abu Shelbayeh O, Arroum T, Morris S, Busch KB (2023) PGC-1alpha Is a Master Regulator of Mitochondrial Lifecycle and ROS Stress Response. Antioxidants (Basel) 12(5). https:\/\/doi.org\/10.3390\/antiox12051075","DOI":"10.3390\/antiox12051075"},{"issue":"1","key":"10296_CR41","doi-asserted-by":"publisher","first-page":"8177","DOI":"10.1038\/s41598-021-87759-x","volume":"11","author":"Y Majeed","year":"2021","unstructured":"Majeed Y, Halabi N, Madani AY, Engelke R, Bhagwat AM, Abdesselem H et al (2021) SIRT1 promotes lipid metabolism and mitochondrial biogenesis in adipocytes and coordinates adipogenesis by targeting key enzymatic pathways. Sci Rep 11(1):8177. https:\/\/doi.org\/10.1038\/s41598-021-87759-x","journal-title":"Sci Rep"},{"key":"10296_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.critrevonc.2017.07.001","volume":"117","author":"A Cormio","year":"2017","unstructured":"Cormio A, Sanguedolce F, Musicco C, Pesce V, Calo G, Bufo P et al (2017) Mitochondrial dysfunctions in bladder cancer: Exploring their role as disease markers and potential therapeutic targets. Crit Rev Oncol Hematol 117:67\u201372. https:\/\/doi.org\/10.1016\/j.critrevonc.2017.07.001","journal-title":"Crit Rev Oncol Hematol"},{"issue":"11","key":"10296_CR43","doi-asserted-by":"publisher","first-page":"1206","DOI":"10.1002\/cbin.11187","volume":"43","author":"M Najafi","year":"2019","unstructured":"Najafi M, Ahmadi A, Mortezaee K (2019) Extracellular-signal-regulated kinase\/mitogen-activated protein kinase signaling as a target for cancer therapy: an updated review. Cell Biol Int 43(11):1206\u20131222. https:\/\/doi.org\/10.1002\/cbin.11187","journal-title":"Cell Biol Int"},{"issue":"3","key":"10296_CR44","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3892\/etm.2020.8454","volume":"19","author":"YJ Guo","year":"2020","unstructured":"Guo YJ, Pan WW, Liu SB, Shen ZF, Xu Y, Hu LL (2020) ERK\/MAPK signalling pathway and tumorigenesis. Exp Ther Med 19(3):1997\u20132007. https:\/\/doi.org\/10.3892\/etm.2020.8454","journal-title":"Exp Ther Med"},{"key":"10296_CR45","doi-asserted-by":"publisher","unstructured":"Sugiura R, Satoh R, Takasaki T (2021) ERK: A Double-Edged Sword in Cancer. ERK-Dependent Apoptosis as a Potential Therapeutic Strategy for Cancer. Cells 10(10):2509. https:\/\/doi.org\/10.3390\/cells10102509","DOI":"10.3390\/cells10102509"}],"container-title":["Probiotics and Antimicrobial Proteins"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-024-10296-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12602-024-10296-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12602-024-10296-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:06:33Z","timestamp":1760619993000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12602-024-10296-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,28]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["10296"],"URL":"https:\/\/doi.org\/10.1007\/s12602-024-10296-2","relation":{},"ISSN":["1867-1306","1867-1314"],"issn-type":[{"value":"1867-1306","type":"print"},{"value":"1867-1314","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,28]]},"assertion":[{"value":"16 May 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}